General anaesthesia

Presentation on the Use of DSUVIA® for Plastic Surgery Procedures Selected for "Best Papers" Session at the California Society of Plastic Surgeons Annual Meeting

Retrieved on: 
Wednesday, May 26, 2021
Medical specialties, Clinical medicine, Medicine, Plastic surgery, Anesthesia, Surgeon, Surgery, Reconstructive surgery, General anaesthesia

Hisham Seify, MD, PhD, FACS will present data on the efficacy and safety of DSUVIA for use in general anesthesia plastic surgery cases, and "awake" cosmetic procedures performed at the Newport Plastic and Reconstructive Surgery's center.

Key Points: 
  • Hisham Seify, MD, PhD, FACS will present data on the efficacy and safety of DSUVIA for use in general anesthesia plastic surgery cases, and "awake" cosmetic procedures performed at the Newport Plastic and Reconstructive Surgery's center.
  • Dr.Seify is a board-certified plastic surgeon and the past-president of the Orange County Society of Plastic Surgeons.
  • DSUVIA was designed to provide rapid analgesia via a non-invasive route and to eliminate dosing errors associated with intravenous (IV) administration.
  • DSUVIA is a single-strength solid dosage form administered sublingually via a single-dose applicator (SDA) by healthcare professionals.

Increasing the Safety of Sedation Before Administering General Anesthesia in Pediatric Patients

Retrieved on: 
Thursday, April 15, 2021
Medical specialties, Anesthesia, Health care, Medicine, American Dental Society of Anesthesiology, Anesthesiology, Sedation, General anaesthesia, Ketamine

b'LAWRENCE, Kan., April 15, 2021 /PRNewswire-PRWeb/ -- Anesthesia Progress It is increasingly more common for pediatric patients to require general anesthesia (GA) for dental procedures; however, uncooperative patients or those with mental disabilities add a greater challenge.

Key Points: 
  • b'LAWRENCE, Kan., April 15, 2021 /PRNewswire-PRWeb/ -- Anesthesia Progress It is increasingly more common for pediatric patients to require general anesthesia (GA) for dental procedures; however, uncooperative patients or those with mental disabilities add a greater challenge.
  • Children, particularly those with special needs, often require intramuscular (IM) sedation for safe and effective transport into the operating room and induction of GA for dental procedures.
  • Of the patients, 59% were younger than 13 years, and 64% had at least one behavioral issue, with autism spectrum disorder being the most common.
  • 1, 2021, is available at https://meridian.allenpress.com/anesthesia-progress/article/68/1/3/46366... .\nAnesthesia Progress is the official publication of the American Dental Society of Anesthesiology (ADSA).

United States $2.4 Billion General Anesthesia Drugs Market to 2025: Focus on Sevoflurane, Desflurane, Isoflurane, NO, Propofol, Benzodiazepines, Ketamine, Methohexital Sodium

Retrieved on: 
Monday, February 22, 2021
Anesthesia, General anaesthesia

The US general anesthesia drugs market is projected to reach USD 2.4 billion by 2025 from USD 2 billion in 2020, at a CAGR of 3.4% during the forecast period.

Key Points: 
  • The US general anesthesia drugs market is projected to reach USD 2.4 billion by 2025 from USD 2 billion in 2020, at a CAGR of 3.4% during the forecast period.
  • Factors such rapid onset of action, introduction of new anesthesia drugs with desired pharmacologic effects is expected to drive the market of intravenous anesthesia drugs.
  • The hospitals segment accounted for the largest share of the US general anesthesia drugs market in 2019.
  • The report also provides a comprehensive review of market drivers, challenges, and opportunities in the US general anesthesia drugs market.

United States General Anesthesia Drugs Market Report 2021: Opportunities in the Patent Expiry of Lusedra - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 17, 2021
Health, Pharmaceutical, Anesthesia, General anaesthesia

The US general anesthesia drugs market is projected to reach USD 2.4 billion by 2025 from USD 2 billion in 2020, at a CAGR of 3.4% during the forecast period.

Key Points: 
  • The US general anesthesia drugs market is projected to reach USD 2.4 billion by 2025 from USD 2 billion in 2020, at a CAGR of 3.4% during the forecast period.
  • Factors such rapid onset of action, introduction of new anesthesia drugs with desired pharmacologic effects is expected to drive the market of intravenous anesthesia drugs.
  • The hospitals segment accounted for the largest share of the US general anesthesia drugs market in 2019.
  • The report also provides a comprehensive review of market drivers, challenges, and opportunities in the US general anesthesia drugs market.

US General Anesthesia Drugs Market worth $2.4 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, February 4, 2021
Drugs, Medical specialties, Receptor agonists, Anesthesia, General anesthetics, GABAA receptor positive allosteric modulators, Sedatives, Nicotinic antagonists, Propofol, General anaesthesia, Ketamine, Benzodiazepine

Based on the route of administration, US general anesthesia drugs market is categorized into inhalational anesthesia drugs and intravenous anesthesia drugs.

Key Points: 
  • Based on the route of administration, US general anesthesia drugs market is categorized into inhalational anesthesia drugs and intravenous anesthesia drugs.
  • Similarly, intravenous anesthesia drugs are further categorized into propofol, benzodiazepines, ketamine, methohexital sodium and others intravenous general anesthesia drugs.
  • General intravenous anesthesia drugs are less expensive and do not require expensive machines for administration which contributes to the high market share of the segment.
  • Based on end user, the US general anesthesia drugs market has been segmented into hospitals and ambulatory surgery centers.

US General Anesthesia Drugs Market worth $2.4 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, February 4, 2021
Drugs, Medical specialties, Receptor agonists, Anesthesia, General anesthetics, GABAA receptor positive allosteric modulators, Sedatives, Nicotinic antagonists, Propofol, General anaesthesia, Ketamine, Benzodiazepine

Based on the route of administration, US general anesthesia drugs market is categorized into inhalational anesthesia drugs and intravenous anesthesia drugs.

Key Points: 
  • Based on the route of administration, US general anesthesia drugs market is categorized into inhalational anesthesia drugs and intravenous anesthesia drugs.
  • Similarly, intravenous anesthesia drugs are further categorized into propofol, benzodiazepines, ketamine, methohexital sodium and others intravenous general anesthesia drugs.
  • General intravenous anesthesia drugs are less expensive and do not require expensive machines for administration which contributes to the high market share of the segment.
  • Based on end user, the US general anesthesia drugs market has been segmented into hospitals and ambulatory surgery centers.

New Study: Postoperative Pain Can Be Reduced by Using NOL Monitoring to Guide Analgesic Medication During Surgery

Retrieved on: 
Tuesday, September 29, 2020
Perception, Clinical medicine, Nociception, Acute pain, Suffering, Pain, Anesthesia, Analgesic, Fentanyl, General anaesthesia

RAMAT GAN, Israel, Sept. 29, 2020 /PRNewswire/ --A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain.

Key Points: 
  • RAMAT GAN, Israel, Sept. 29, 2020 /PRNewswire/ --A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain.
  • Exploring the potential use of NOL monitoring to help enhance recovery after surgery, the study demonstrated that patient pain scores after surgery were 33% lower when administration of pain medication during surgery was guided with NOL monitoring.
  • "Clinicians using NOL monitoring to guide analgesia are able to identify more accurately when a patient's pain response level rises and to tailor analgesic medication more accurately.
  • Reduced postoperative pain using Nociception Level-guided fentanyl dosing during sevoflurane anaesthesia: a randomised controlled trial.

New Study: Postoperative Pain Can Be Reduced by Using NOL Monitoring to Guide Analgesic Medication During Surgery

Retrieved on: 
Tuesday, September 29, 2020
Perception, Clinical medicine, Nociception, Acute pain, Suffering, Pain, Anesthesia, Analgesic, Fentanyl, General anaesthesia

RAMAT GAN, Israel, Sept. 29, 2020 /PRNewswire/ --A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain.

Key Points: 
  • RAMAT GAN, Israel, Sept. 29, 2020 /PRNewswire/ --A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain.
  • Exploring the potential use of NOL monitoring to help enhance recovery after surgery, the study demonstrated that patient pain scores after surgery were 33% lower when administration of pain medication during surgery was guided with NOL monitoring.
  • "Clinicians using NOL monitoring to guide analgesia are able to identify more accurately when a patient's pain response level rises and to tailor analgesic medication more accurately.
  • Reduced postoperative pain using Nociception Level-guided fentanyl dosing during sevoflurane anaesthesia: a randomised controlled trial.

New Blinded Observational Study Shows Greater Depth of Patient Sedation Than Intended During Procedural Colonoscopy

Retrieved on: 
Monday, August 3, 2020
Biotechnology, Surgery, Medical devices, Health, Pharmaceutical, Medical specialties, Clinical medicine, Medicine, Sedation, Procedural sedation and analgesia, Propofol, Anesthesia, Burst suppression, Electroencephalography, Colonoscopy, General anaesthesia

Anesthesiologists and endoscopists may utilize processed EEG to recognize their institutional practice patterns of procedural sedation with propofol and improve upon it.

Key Points: 
  • Anesthesiologists and endoscopists may utilize processed EEG to recognize their institutional practice patterns of procedural sedation with propofol and improve upon it.
  • Based on the study results, the researchers concluded, The depth of sedation achieved with anesthesia administered propofol for colonoscopy spans a continuum.
  • Although providers planned for moderate to deep sedation, processed EEG in this study revealed a substantially greater depth consistent with general anesthesia and even burst suppression.
  • Further research is required to establish the impact on patient outcomes of anesthetic practices resulting in intraprocedural burst suppression.

Visiongain Publishes Global Inhalation Anaesthesia Market 2019-2029 Report

Retrieved on: 
Wednesday, December 11, 2019
Medical specialties, Drugs, Psychoactive drugs, General anesthetics, NMDA receptor antagonists, Nicotinic antagonists, Anesthesia, Anesthesiology, Anesthetic, General anaesthesia, Inhalational anesthetic, Ketamine

IA has lower risk of delirium and is cost effective compared to IVA

Key Points: 
  • IA has lower risk of delirium and is cost effective compared to IVA
    Inhalational anesthesia used for sedation as well as for the induction and maintenance of general anesthesia.
  • To address the environmental impact of anesthetic gases, new technologies are being developed to scavenge them from hospital vents and recycle them.
  • These anesthetic gases contribute up to 1.0% of global carbon dioxide emissions, leading to greater environmental damage.
  • The inhalation anesthesia market is segmented on the product type, application, and geography.